62.44
Arcellx Inc Borsa (ACLX) Ultime notizie
Arcellx, Inc. (NASDAQ:ACLX) Stake Lessened by Corebridge Financial Inc. - Defense World
Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday - Benzinga
What You Didn’t Know About Arcellx Inc (NASDAQ: ACLX) This Week - stocksregister.com
Arcellx Inc (ACLX) rating initates by Redburn Atlantic - knoxdaily.com
Teacher Retirement System of Texas Purchases 1,505 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
In 2025, Will Arcellx Inc (NASDAQ: ACLX) Be Bullish Or Bearish? - Stocks Register
How To Trade (ACLX) - news.stocktradersdaily.com
Swiss National Bank Buys 500 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Raymond James Financial Inc. Acquires New Position in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of Directors - BioSpace
Arcellx Inc Announces Board Changes for Strategic Growth - TipRanks
Arcellx names new board members, gears up for 2026 launch By Investing.com - Investing.com Australia
Arcellx Appoints Andrew Galligan And Kristin Myers To Its Board Of Directors -March 20, 2025 at 04:42 pm EDT - MarketScreener
Arcellx names new board members, gears up for 2026 launch - Investing.com
Arcellx Bolsters Commercial Strategy: Key Healthcare Veterans Join Board for Myeloma Drug Launch - Stock Titan
Arcellx director Kavita Patel sells $107,460 in common stock By Investing.com - Investing.com Australia
Arcellx director Kavita Patel sells $107,460 in common stock - Investing.com India
Arcellx CMO Discusses Novel Investigational CAR-T Therapy During Multiple Myeloma Awareness Month - The Manila Times
Charles Schwab Investment Management Inc. Buys 14,992 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Arcellx Impressive Safety Data Leaves Doubts (NASDAQ:ACLX) - Seeking Alpha
Bank of New York Mellon Corp Buys 27,350 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
US Bancorp DE Has $462,000 Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
ACLX June 20th Options Begin Trading - Nasdaq
Arcellx (NASDAQ:ACLX) Shares Gap Up – Time to Buy? - Defense World
Principal Financial Group Inc. Trims Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Myesha Lacy - ir-impact.com
CAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain - GlobeNewswire Inc.
Need To Know: Analysts Just Made A Substantial Cut To Their Arcellx, Inc. (NASDAQ:ACLX) Estimates - Simply Wall St
We're Not Worried About Arcellx's (NASDAQ:ACLX) Cash Burn - Yahoo Finance
New York State Common Retirement Fund Has $1.55 Million Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
HC Wainwright Predicts Arcellx’s Q1 Earnings (NASDAQ:ACLX) - Defense World
Optimistic Buy Rating for Arcellx Inc: Promising CAR-T Therapy and Strong Financial Position Highlighted - TipRanks
Arcellx Reports Promising 2024 Financial and Clinical Progress - MSN
Arcellx (NASDAQ:ACLX) Posts Earnings Results, Misses Estimates By $0.24 EPS - MarketBeat
Kavita Patel Sells 1,500 Shares of Arcellx, Inc. (NASDAQ:ACLX) Stock - MarketBeat
State of New Jersey Common Pension Fund D Purchases New Stake in Arcellx, Inc. (NASDAQ:ACLX) - MarketBeat
Arcellx, Inc. (ACLX) Reports Q4 Loss, Lags Revenue Estimates - MSN
Why Arcellx Inc Stocks Are on the Rise - TipRanks
Arcellx Inc’s Anito-cel: Anticipated Market Leader with Strong Efficacy, Safety, and Financial Position - TipRanks
Arcellx Inc: Buy Rating Affirmed on Promising Anito-cel Therapy and Strong Financial Position - TipRanks
Arcellx Inc’s Anito-cel Therapy: Promising Clinical Results and Strategic Partnerships Support Buy Rating - TipRanks
Arcellx Inc’s Anito-cel: Promising Performance and Positive Outlook with Buy Rating - TipRanks
Arcellx, Inc. (NASDAQ:ACLX) Shares Bought by Rhumbline Advisers - Defense World
Rami Elghandour Sells 38,300 Shares of Arcellx, Inc. (NASDAQ:ACLX) Stock - MarketBeat
Arcellx Provides Fourth Quarter and Year-End 2024 Financial Results and Business Highlights - BioSpace
Arcellx earnings missed by $0.31, revenue fell short of estimates - Investing.com UK
Arcellx reports FY24 EPS ($2.00), consensus ($1.50) - TipRanks
Arcellx CEO Rami Elghandour sells $2.38 million in stock By Investing.com - Investing.com South Africa
Arcellx CEO Rami Elghandour sells $2.38 million in stock - Investing.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):